Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
出版年份 2018 全文链接
标题
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
作者
关键词
-
出版物
Advanced Science
Volume -, Issue -, Pages 1801585
出版商
Wiley
发表日期
2018-12-12
DOI
10.1002/advs.201801585
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Immune Responses in the Liver
- (2018) Paul Kubes et al. Annual Review of Immunology
- Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
- (2018) Juan Pablo Arab et al. Annual Review of Pathology-Mechanisms of Disease
- Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies
- (2018) Julia Wattacheril et al. Annual Review of Pharmacology and Toxicology
- TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue
- (2018) Peng Zhao et al. CELL
- Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
- (2018) Varman T. Samuel et al. Cell Metabolism
- Time to step-up the fight against NAFLD
- (2018) Xiao-Jing Zhang et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis
- (2018) Alexander J. Kovalic et al. Hepatology International
- Dusp14 protects against hepatic ischaemia–reperfusion injury via Tak1 suppression
- (2018) Xiaozhan Wang et al. JOURNAL OF HEPATOLOGY
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study
- (2018) S. Harrison et al. JOURNAL OF HEPATOLOGY
- The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
- (2018) Marie Boyle et al. JOURNAL OF HEPATOLOGY
- Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions
- (2018) Rohit Loomba JOURNAL OF HEPATOLOGY
- Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1
- (2018) Juan-Juan Qin et al. JOURNAL OF HEPATOLOGY
- Determinants of fibrosis progression and regression in NASH
- (2018) Detlef Schuppan et al. JOURNAL OF HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Pharmacotherapy for NASH: Current and emerging
- (2018) Monica A. Konerman et al. JOURNAL OF HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Preclinical models of non-alcoholic fatty liver disease
- (2018) Prasanna K. Santhekadur et al. JOURNAL OF HEPATOLOGY
- Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
- (2018) Thomas Jensen et al. JOURNAL OF HEPATOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future
- (2018) Ana Ruth Araújo et al. LIVER INTERNATIONAL
- The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
- (2018) Yan-Xiao Ji et al. NATURE MEDICINE
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD
- (2018) Elliot B. Tapper et al. Nature Reviews Gastroenterology & Hepatology
- Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
- (2018) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
- (2018) Vincent Wai-Sun Wong et al. Nature Reviews Gastroenterology & Hepatology
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
- (2018) Christopher D Byrne et al. BMJ-British Medical Journal
- Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
- (2018) Christopher D Byrne et al. BMJ-British Medical Journal
- Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease
- (2018) Jingjing Cai et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation
- (2017) David Goldberg et al. GASTROENTEROLOGY
- The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis
- (2017) Feng-Juan Yan et al. HEPATOLOGY
- USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity
- (2017) Shimin An et al. HEPATOLOGY
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance
- (2017) Quan-Yu Zhang et al. HEPATOLOGY
- Reprogramming Innate Immune Signaling in Cardiometabolic Disease
- (2017) Yaxing Zhang et al. HYPERTENSION
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury
- (2017) Xiao-Jing Zhang et al. NATURE MEDICINE
- Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
- (2017) Pi-Xiao Wang et al. NATURE MEDICINE
- The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
- (2017) Peng Zhang et al. NATURE MEDICINE
- Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
- (2017) Guang-Nian Zhao et al. NATURE MEDICINE
- Endocrine-disrupting chemicals and fatty liver disease
- (2017) Charles E. Foulds et al. Nature Reviews Endocrinology
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- (2017) Anna M. Diehl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatty liver promotes fibrosis in monkeys consuming high fructose
- (2017) Michael A. Cydylo et al. Obesity
- Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases
- (2017) Yaxing Zhang et al. PHYSIOLOGY
- Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance
- (2017) Joonseok Cho et al. Nature Communications
- Epigenetics and Trained Immunity
- (2017) Charlotte D.C.C. van der Heijden et al. ANTIOXIDANTS & REDOX SIGNALING
- Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance
- (2016) Pengcheng Luo et al. AMERICAN JOURNAL OF PATHOLOGY
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
- (2016) Timothy Hardy et al. Annual Review of Pathology-Mechanisms of Disease
- Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
- (2016) Joel T. Haas et al. Annual Review of Physiology
- Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites
- (2016) You Zhou et al. Clinical Gastroenterology and Hepatology
- Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
- (2016) Quentin M. Anstee et al. GASTROENTEROLOGY
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
- (2016) Yaron Rotman et al. GUT
- The increasing burden of nonalcoholic fatty liver disease among young adults in the United States: A growing epidemic
- (2016) Rachel Abou Mrad et al. HEPATOLOGY
- Liver capsule: IRFs in hepatocytes: Pathophysiology
- (2016) Pi-Xiao Wang et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Gut Microbiota and Lifestyle Interventions in NAFLD
- (2016) David Houghton et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis
- (2016) Ling Gao et al. JOURNAL OF HEPATOLOGY
- Sitagliptin Versus Placebo in the Treatment of Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial
- (2016) J.Y. Cui et al. JOURNAL OF HEPATOLOGY
- Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
- (2016) Mei Xiang et al. JOURNAL OF HEPATOLOGY
- DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity
- (2016) Lanfeng Xie et al. JOURNAL OF HEPATOLOGY
- Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury
- (2016) Junfei Hu et al. JOURNAL OF HEPATOLOGY
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
- (2016) Amon Asgharpour et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Signals from the gut microbiota to distant organs in physiology and disease
- (2016) Bjoern O Schroeder et al. NATURE MEDICINE
- Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
- (2016) Giovanni Musso et al. NATURE REVIEWS DRUG DISCOVERY
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- Endoplasmic reticulum proteostasis in hepatic steatosis
- (2016) Andrei Baiceanu et al. Nature Reviews Endocrinology
- NAFLD and diabetes mellitus
- (2016) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- Developmental origins of NAFLD: a womb with a clue
- (2016) Stephanie R. Wesolowski et al. Nature Reviews Gastroenterology & Hepatology
- The role of the gut microbiota in NAFLD
- (2016) Christopher Leung et al. Nature Reviews Gastroenterology & Hepatology
- Management of NAFLD: a stage-based approach
- (2016) Mary E. Rinella et al. Nature Reviews Gastroenterology & Hepatology
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
- (2016) Obesity Facts
- Trained immunity: A program of innate immune memory in health and disease
- (2016) M. G. Netea et al. SCIENCE
- Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
- (2016) Pi-Xiao Wang et al. Nature Communications
- The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
- (2016) Yan-Xiao Ji et al. Nature Communications
- Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
- (2016) Ke-Qiong Deng et al. Nature Communications
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
- (2015) I. Doycheva et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy
- (2015) Jeremy Lok Wei et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis
- (2015) Andrew A. Pierce et al. BMC GASTROENTEROLOGY
- The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases
- (2015) Xiao-Jing Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-alcoholic fatty liver disease following liver transplantation: a clinical review
- (2015) Jonathan Merola et al. CLINICAL TRANSPLANTATION
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
- (2015) Robert J. Wong et al. GASTROENTEROLOGY
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Zebrafish: An Important Tool for Liver Disease Research
- (2015) Wolfram Goessling et al. GASTROENTEROLOGY
- Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
- (2015) Paola Dongiovanni et al. HEPATOLOGY
- Tumor Necrosis Factor Receptor–Associated Factor 3 Is a Positive Regulator of Pathological Cardiac HypertrophyNovelty and Significance
- (2015) Xi Jiang et al. HYPERTENSION
- Interferon Regulatory Factor Signalings in Cardiometabolic Diseases
- (2015) Xiao-Jing Zhang et al. HYPERTENSION
- The Cellular and Molecular Basis of Translational Immunometabolism
- (2015) Giuseppe Danilo Norata et al. IMMUNITY
- Hepatitis regulation by the inflammasome signaling pathway
- (2015) Amina A. Negash et al. IMMUNOLOGICAL REVIEWS
- Nonalcoholic Fatty Liver Disease
- (2015) Mary E. Rinella JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mindin deficiency protects the liver against ischemia/reperfusion injury
- (2015) Peng Sun et al. JOURNAL OF HEPATOLOGY
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- LP37 : A placebo-controlled, multicenter, double-blind, randomised trial of emricasan in subjects with non-alcoholic fatty liver disease (NAFLD) and raised transaminases
- (2015) M. Shiffman et al. JOURNAL OF HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Current efforts and trends in the treatment of NASH
- (2015) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury
- (2015) Pi-Xiao Wang et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Leptin in nonalcoholic fatty liver disease: A narrative review
- (2015) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Caring for children with NAFLD and navigating their care into adulthood
- (2015) Ali A. Mencin et al. Nature Reviews Gastroenterology & Hepatology
- Prednisolone or Pentoxifylline for Alcoholic Hepatitis
- (2015) Mark R. Thursz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic fatty liver disease
- (2015) Elizabeth M. Brunt et al. Nature Reviews Disease Primers
- Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors
- (2014) N Gehrke et al. CELL DEATH AND DIFFERENTIATION
- Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
- (2014) Carlos J Pirola et al. GUT
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- The global burden of liver disease: The major impact of China
- (2014) Fu-Sheng Wang et al. HEPATOLOGY
- Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease
- (2014) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice
- (2014) Li-Hua Zhu et al. JOURNAL OF HEPATOLOGY
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Ubiquitination in disease pathogenesis and treatment
- (2014) Doris Popovic et al. NATURE MEDICINE
- Necroptosis
- (2014) Andreas Linkermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content
- (2014) H. Mahdessian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver
- (2014) Xiaomang Xing et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- TRAF1 is a key mediator for hepatic ischemia/reperfusion injury
- (2014) X-F Zhang et al. Cell Death & Disease
- TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
- (2014) Yang-Lin Liu et al. Nature Communications
- Interferon regulatory factor 9 is critical for neointima formation following vascular injury
- (2014) Shu-Min Zhang et al. Nature Communications
- IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling
- (2014) Ding-Sheng Jiang et al. Nature Communications
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
- (2014) Hannele Yki-Järvinen Lancet Diabetes & Endocrinology
- Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease
- (2013) E. Scorletti et al. Annual Review of Nutrition
- Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice
- (2013) Xin-An Wang et al. HEPATOLOGY
- Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance
- (2013) Xin-An Wang et al. HEPATOLOGY
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- Disruption of Tumor Necrosis Factor Receptor Associated Factor 5 Exacerbates Pressure Overload Cardiac Hypertrophy and Fibrosis
- (2013) Zhouyan Bian et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene
- (2013) Hwa-Li Tan et al. JOURNAL OF GASTROENTEROLOGY
- Epidemiology of alcoholic and nonalcoholic fatty liver disease in China
- (2013) Jian-Gao Fan JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- From NAFLD in clinical practice to answers from guidelines
- (2013) Fabio Nascimbeni et al. JOURNAL OF HEPATOLOGY
- The liver diseases of lipodystrophy: The long-term effect of leptin treatment
- (2013) Elika Safar Zadeh et al. JOURNAL OF HEPATOLOGY
- Tumor necrosis factor receptor-associated factor 5 is an essential mediator of ischemic brain infarction
- (2013) Lang Wang et al. JOURNAL OF NEUROCHEMISTRY
- Lifestyle intervention in childhood obesity: changes and challenges
- (2013) Thomas Reinehr Nature Reviews Endocrinology
- Noninvasive evaluation of NAFLD
- (2013) Laurent Castera et al. Nature Reviews Gastroenterology & Hepatology
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- NAFLD in Asia—as common and important as in the West
- (2013) Geoffrey C. Farrell et al. Nature Reviews Gastroenterology & Hepatology
- From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
- (2013) Alexander Wree et al. Nature Reviews Gastroenterology & Hepatology
- The genetics of NAFLD
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Pharmacological agents for NASH
- (2013) Vlad Ratziu Nature Reviews Gastroenterology & Hepatology
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- TRAF1 is a critical regulator of cerebral ischaemia–reperfusion injury and neuronal death
- (2013) Yan-Yun Lu et al. Nature Communications
- Endoplasmic Reticulum Stress in Nonalcoholic Fatty Liver Disease
- (2012) Michael J. Pagliassotti Annual Review of Nutrition
- Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units
- (2012) Xiaona Hu et al. BMC GASTROENTEROLOGY
- Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
- (2012) Christopher K. Glass et al. Cell Metabolism
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
- (2012) Claudia O. Zein et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
- (2012) Carlo Pirazzi et al. JOURNAL OF HEPATOLOGY
- Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
- (2012) Mariana V. Machado et al. JOURNAL OF HEPATOLOGY
- Multigenerational epigenetic adaptation of the hepatic wound-healing response
- (2012) Müjdat Zeybel et al. NATURE MEDICINE
- Physical activity: an essential component of lifestyle modification in NAFLD
- (2012) Benjamin Rodriguez et al. Nature Reviews Gastroenterology & Hepatology
- Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach
- (2012) Anna Alisi et al. Nature Reviews Gastroenterology & Hepatology
- Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
- (2012) Enzo Bonora et al. Nature Reviews Gastroenterology & Hepatology
- Signaling in Innate Immunity and Inflammation
- (2012) K. Newton et al. Cold Spring Harbor Perspectives in Biology
- Pathogenesis of Liver Fibrosis
- (2011) Virginia Hernandez-Gea et al. Annual Review of Pathology-Mechanisms of Disease
- Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction
- (2011) Jinfeng Xiao et al. BASIC RESEARCH IN CARDIOLOGY
- Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
- (2011) Vincent Wai-Sun Wong et al. GUT
- Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
- (2011) Christer Baeck et al. GUT
- Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
- (2011) K. Hallsworth et al. GUT
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease
- (2011) Yongcheng Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease
- (2011) Leon A Adams et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
- (2011) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies
- (2011) Ahmad Al-Serri et al. JOURNAL OF HEPATOLOGY
- Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
- (2011) Christian Thoma et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment
- (2011) Briohny W. Smith et al. Nature Reviews Endocrinology
- Human Fatty Liver Disease: Old Questions and New Insights
- (2011) J. C. Cohen et al. SCIENCE
- Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease
- (2011) Ann K Daly et al. Expert Review of Gastroenterology & Hepatology
- Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Musso et al. Annual Review of Medicine
- Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
- (2010) Dina G. Tiniakos et al. Annual Review of Pathology-Mechanisms of Disease
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans
- (2010) Ronald J. A. Wanders et al. FEBS Journal
- Type I Interferons Protect From Toll-Like Receptor 9–Associated Liver Injury and Regulate IL-1 Receptor Antagonist in Mice
- (2010) Jan Petrasek et al. GASTROENTEROLOGY
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
- (2010) S. McPherson et al. GUT
- Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
- (2010) Manal F. Abdelmalek et al. HEPATOLOGY
- Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease
- (2010) Kausik Das et al. HEPATOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
- (2010) Elizabeth M. Brunt et al. HEPATOLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Macaca radiata (bonnet monkey): a spontaneous model of nonalcoholic fatty liver disease
- (2010) Perumal Nagarajan et al. LIVER INTERNATIONAL
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- Pathology of nonalcoholic fatty liver disease
- (2010) Elizabeth M. Brunt Nature Reviews Gastroenterology & Hepatology
- Animal models of nonalcoholic fatty liver disease
- (2010) Lionel Hebbard et al. Nature Reviews Gastroenterology & Hepatology
- The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
- (2010) Jung Sub Lim et al. Nature Reviews Gastroenterology & Hepatology
- The role of the gut microbiota in nonalcoholic fatty liver disease
- (2010) Ahmed Abu-Shanab et al. Nature Reviews Gastroenterology & Hepatology
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic Fatty Liver Disease and Low-Carbohydrate Diets
- (2009) Linda Wasserbach York et al. Annual Review of Nutrition
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
- Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
- (2009) Anna Kotronen et al. GASTROENTEROLOGY
- Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine
- (2009) Lydia Lee et al. HEPATOLOGY
- Autophagy regulates lipid metabolism
- (2009) Rajat Singh et al. NATURE
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
- Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist
- (2008) Edward E. Cable et al. HEPATOLOGY
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
- (2008) Stephen A. Harrison et al. HEPATOLOGY
- Non-alcoholic fatty liver disease: The mist gradually clears
- (2008) Nimantha Mark Wilfred de Alwis et al. JOURNAL OF HEPATOLOGY
- Epidemiology of non-alcoholic fatty liver disease in China
- (2008) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
- Insulin resistance, inflammation, and non-alcoholic fatty liver disease
- (2008) Herbert Tilg et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started